Clinical Trial Update: Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of naftopidil for patients with hyperplasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperplasia

Drugs mentioned

• Naftopidil (Naftopidil)

Snippet

Sponsor: Apsen Farmaceutica S.A. | Conditions: Hyperplasia | Phase 3 | Status: WITHDRAWN